JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

10.73 1.9

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.42

Max

11.01

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+4.56% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-46M

870M

Ouverture précédente

8.83

Clôture précédente

10.73

Sentiment de l'Actualité

By Acuity

50%

50%

179 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 avr. 2026, 23:33 UTC

Résultats

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 avr. 2026, 22:40 UTC

Résultats

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 avr. 2026, 22:10 UTC

Acquisitions, Fusions, Rachats

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 avr. 2026, 21:11 UTC

Résultats

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 avr. 2026, 21:01 UTC

Résultats

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 avr. 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22 avr. 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 avr. 2026, 23:34 UTC

Market Talk
Principaux Événements d'Actualité

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 avr. 2026, 23:16 UTC

Résultats

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 avr. 2026, 23:15 UTC

Résultats

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 avr. 2026, 22:54 UTC

Résultats

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 avr. 2026, 22:54 UTC

Résultats

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 avr. 2026, 22:52 UTC

Résultats

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 avr. 2026, 22:51 UTC

Résultats

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 avr. 2026, 22:31 UTC

Résultats

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 avr. 2026, 22:31 UTC

Résultats

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 avr. 2026, 22:30 UTC

Résultats

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 avr. 2026, 22:30 UTC

Résultats

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 avr. 2026, 22:29 UTC

Résultats

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 avr. 2026, 22:28 UTC

Résultats

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 avr. 2026, 22:28 UTC

Résultats

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 avr. 2026, 22:27 UTC

Résultats

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 avr. 2026, 22:06 UTC

Market Talk
Résultats

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 avr. 2026, 21:55 UTC

Acquisitions, Fusions, Rachats

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 avr. 2026, 21:47 UTC

Résultats

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 avr. 2026, 21:37 UTC

Résultats

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 avr. 2026, 21:34 UTC

Résultats

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 avr. 2026, 21:29 UTC

Résultats

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 avr. 2026, 21:20 UTC

Market Talk
Résultats

Tesla Expands Manufacturing to Chips -- Market Talk

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

4.56% hausse

Prévisions sur 12 Mois

Moyen 11 USD  4.56%

Haut 12 USD

Bas 9 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

6 ratings

0

Achat

4

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

179 / 348Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat